Harms of Prescription Opioid Use in the U.S.

by / 0 Comments / 14 View / December 7, 2014

Harms of prescription opioid use in the United States

Consumption levels of prescription opioids (POs) have increased substantially worldwide, particularly the United States. An emerging  perspective implicates increasing consumption levels of POs as the primary system level driving factor behind the observed PO-related harms.  As such, the present study aimed to assess the correlations between consumption levels of POs and PO-related harms, including non-medical  prescription opioid use (NMPOU), PO-related morbidity and PO-related mortality.
Pearson’s product-moment correlations were computed using published data from the United States (2001–2010). Consumption levels of POs  were extracted from the technical reports published by the International Narcotics Control Board, while data for NMPOU was utilized from the  National Survey on Drug Use and Health. Additionally, data for PO-related morbidity (substance abuse treatment admissions per 10,000  people) and PO-related mortality (PO overdose deaths per 100,000 people) were obtained from published studies. Consumption levels of POs were significantly correlated with prevalence of NMPOU in the past month (r =0.741, 95% CI =0.208–0.935), past year (r =0.638, 95% CI  =0.014–0.904) and lifetime (r =0.753, 95% CI =0.235-0.938), as well as average number of days per person per year of NMPOU among the  general population (r =0.900, 95% CI =0.625-0.976) and NMPOU users (r =0.720, 95% CI =0.165–0.929). Similar results were also obtained  for PO-related morbidity and PO-related mortality measures.
These findings suggest that reducing consumption levels of POs at the population level may be an effective strategy to limit PO-related harms.
For the full version of the article click here: Harms of prescription opioid use in the United States

Your Commment

Email (will not be published)